Use: Labeled indications
- INDICATIONS AND USAGE: Mycozyl AL™ is effective in the treatment of most skin infections such as athlete's foot (tinea pedis) and ringworm (tinea corporis).
Full indications and usage US FDA label
INDICATIONS AND USAGE: Mycozyl AL™ is effective in the treatment of most skin infections such as athlete's foot (tinea pedis) and ringworm (tinea corporis). Mycozyl AL™ has been designed to reach skin areas around and under the nails while it relives burning, cracking, scaling and discomfort which accompany these conditions.
Mycozyl AL™ is an antifungal that works by preventing and eliminating the growth of fungus on fingers, toes and around the nails. It eliminates and helps stop the spread of fungal infections on cuticles around nail edges and under the nail tips where reachable with applicator brush. Mycozyl AL™ cures and prevents fungal infections from coming back with daily use.
Contraindications
CONTRAINDICATIONS: Tolnaftate topically applied is not likely to affect drugs taken or injected, but many drugs can interact with each other.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION:
- Clean the affected area with soap and warm water and dry thoroughly
- Apply a thin layer of product over affected area twice daily (morning and night) paying special attention to the edges of the nail, cuticles and skin around the nails or as directed by a doctor
- The brush applicator allows for easy application on skin around the nail and cuticle areas.
- For athlete's foot, pay special attention to spaces between the toes, wear well-fitting,ventilated shoes, and change shoes and socks at least once daily.
- For athlete's foot and ringworm, use daily for 4 weeks.
- Supervise children in the use of this product. Use under the direction of a licensed medical practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 1
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosing: Pediatric
Pediatric use (US label) US FDA label
Pediatric Use: Safety and effectiveness have not been established in pediatric patients less than 2 years of age.
Dosage forms
Philippines
- Ointment: 10 mg/g
- ) cream: 10 mg/g
- Cream: 10 mg/g
- Topical cream: 10 mg
- Topical solution: 10 mg/mL
Registered products in the Philippines
8 products registered with the Food and Drug Administration (FDA) Philippines list Tolnaftate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products8
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
DermactinTolnaftate | 10 mg/g OintmentLaminated Aluminum Tube x 10 g, 15 g, and 30 g (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | — | DRP-1910 | Oct 3, 2028 | |
Healthcare TineaTolnaftate | 1% (10 mg/g) CreamAluminum Tube x 15 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY39339 (For Export Only) | Apr 19, 2031 | |
Healthcare TineaTolnaftate | 10 mg/mL (1% w/v) Topical SolutionLDPE White Plastic Bottle x 30 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY42139 | Jun 20, 2028 | |
NoneTolnaftate | 10 mg/g OintmentLaminated Aluminum Tube x 10 g and 30 g (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | Neodrug Inc. | DRP-1910-02 | Oct 3, 2028 | |
NoneTolnaftate | 10 mg/g OintmentLaminated Aluminum Tube x 15 g (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | Ritemed Phils., Inc. | DRP-1910-03 | Oct 3, 2028 | |
TinactinTolnaftate | 10 mg/g OintmentAluminum Tube with PP Cap x 5 g (Box of 1's) | Rx | Interphil Laboratories, Inc.Philippines | Trader: Bayer Philippines, Inc. | DR-XY47269 | May 11, 2031 | |
TolnactinTolnaftate | 10 mg/g (1% w/w) Cream15 g Collapsible Aluminum Tube (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | TGP Pharma, Inc.Trader: D.B. Manix International, Inc. | DR-XY40290 | Nov 14, 2031 | |
UnbrandedTolnaftate | 10 mg (1% w/w) Topical CreamCollapsible Aluminum Tube x 10 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | — | DR-XY40458 | Dec 26, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS: For External Use Only. Not For Ophthalmic Use
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS: For athlete’s foot and ringworm - if irritation occurs or there is no improvement within 4 weeks. For prevention of athlete’s foot – if irritation occurs, discontinue use and consult a doctor.
Pregnancy considerations
Pregnancy (US label) US FDA label
Pregnancy: Teratogenic effects - There is currently no published human data available on the teratogenic and fetotoxic effects of tolnaftate.
Breastfeeding considerations
Lactation (US label) US FDA label
Nursing Mothers: Before using this medication while breastfeeding, it is recommended to consult with a healthcare professional.
Pharmacokinetics
Pharmacokinetics (US label) US FDA label
Pharmacokinetics: Tolnaftate is only given topically, and there are no documented reports on its pharmacokinetics and systemic metabolism.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Mycozyl AL · PURETEK CORPORATION [US FDA-approved label, version 1, October 17, 2023]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07edd043-4ac4-b2de-e063-6394a90af25d
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .